Nyxoah S.A. (NYXH)
USD 6.12
(1.75%)
USD 6.12
(1.75%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -45.1 Million EUR | -40.45% |
| 2022 | -32.49 Million EUR | -23.84% |
| 2021 | -26.24 Million EUR | -133.8% |
| 2020 | -11.22 Million EUR | -72.25% |
| 2019 | -6.51 Million EUR | 22.89% |
| 2018 | -8.45 Million EUR | 16.69% |
| 2017 | -10.14 Million EUR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -12.4 Million EUR | -11.61% |
| 2024 Q2 | -13.36 Million EUR | -7.25% |
| 2023 Q1 | -11.39 Million EUR | -25.92% |
| 2023 Q3 | -10.98 Million EUR | 7.55% |
| 2023 Q2 | -11.88 Million EUR | -4.27% |
| 2023 FY | -45.64 Million EUR | -40.45% |
| 2023 Q4 | -11.11 Million EUR | -1.18% |
| 2022 Q2 | -7.39 Million EUR | -1.51% |
| 2022 Q1 | -7.28 Million EUR | -11.28% |
| 2022 FY | -32.49 Million EUR | -23.84% |
| 2022 Q3 | -8.77 Million EUR | -18.77% |
| 2022 Q4 | -9.05 Million EUR | -3.1% |
| 2021 Q2 | -6.3 Million EUR | -18.45% |
| 2021 Q3 | -8.07 Million EUR | -27.99% |
| 2021 FY | -26.24 Million EUR | -133.8% |
| 2021 Q4 | -6.54 Million EUR | 18.92% |
| 2021 Q1 | -5.32 Million EUR | -46.2% |
| 2020 Q3 | -3.64 Million EUR | -134.15% |
| 2020 Q1 | -2.05 Million EUR | 9.41% |
| 2020 FY | -11.22 Million EUR | -72.25% |
| 2020 Q4 | -3.64 Million EUR | 0.0% |
| 2020 Q2 | -1.55 Million EUR | 24.15% |
| 2019 Q3 | -2.26 Million EUR | -41.93% |
| 2019 Q4 | -2.26 Million EUR | 0.0% |
| 2019 Q2 | -1.59 Million EUR | 0.0% |
| 2019 FY | -6.51 Million EUR | 22.89% |
| 2019 Q1 | -1.59 Million EUR | 0.0% |
| 2018 FY | -8.45 Million EUR | 16.69% |
| 2017 FY | -10.14 Million EUR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Akoya Biosciences, Inc. | -57.66 Million USD | 21.79% |
| AngioDynamics, Inc. | -97.71 Million USD | 53.845% |
| AtriCure, Inc. | -26.68 Million USD | -69.029% |
| Avinger, Inc. | -16.63 Million USD | -171.127% |
| Azenta, Inc. | -73.12 Million USD | 38.323% |
| BioLife Solutions, Inc. | -70.82 Million USD | 36.319% |
| The Cooper Companies, Inc. | 533.1 Million USD | 108.46% |
| Daxor Corporation | -177.07 Thousand USD | -25370.563% |
| Ekso Bionics Holdings, Inc. | -15.11 Million USD | -198.452% |
| Femasys Inc. | -14.5 Million USD | -210.868% |
| GlucoTrack, Inc. | -7.1 Million USD | -534.882% |
| Harvard Bioscience, Inc. | 1.89 Million USD | 2481.309% |
| Hologic, Inc. | 882.6 Million USD | 105.11% |
| ICU Medical, Inc. | 22.82 Million USD | 297.599% |
| Intuitive Surgical, Inc. | 1.76 Billion USD | 102.553% |
| KORU Medical Systems, Inc. | -10.26 Million USD | -339.164% |
| LeMaitre Vascular, Inc. | 37.08 Million USD | 221.628% |
| Innovative Eyewear, Inc. | -6.9 Million USD | -553.601% |
| Innovative Eyewear, Inc. | -6.9 Million USD | -553.601% |
| Masimo Corporation | 136.5 Million USD | 133.042% |
| Microbot Medical Inc. | -9.85 Million USD | -357.656% |
| Meihua International Medical Technologies Co., Ltd. | 14.67 Million USD | 407.34% |
| Merit Medical Systems, Inc. | 123.94 Million USD | 136.389% |
| Nephros, Inc. | -1.59 Million USD | -2731.262% |
| NovoCure Limited | -232.87 Million USD | 80.632% |
| NEXGEL, Inc. | -3.47 Million USD | -1197.153% |
| NEXGEL, Inc. | -3.47 Million USD | -1197.153% |
| Singular Genomics Systems, Inc. | -102.8 Million USD | 56.127% |
| OraSure Technologies, Inc. | 54.07 Million USD | 183.4% |
| Pro-Dex, Inc. | 7.17 Million USD | 728.775% |
| Pulse Biosciences, Inc. | -43.57 Million USD | -3.507% |
| Predictive Oncology Inc. | -13.92 Million USD | -223.978% |
| Precision Optics Corporation, Inc. | -2.72 Million USD | -1555.524% |
| QuidelOrtho Corporation | 139.1 Million USD | 132.424% |
| Repligen Corporation | 54.57 Million USD | 182.641% |
| Sanara MedTech Inc. | -4.21 Million USD | -969.997% |
| STAAR Surgical Company | 28.09 Million USD | 260.522% |
| Sharps Technology, Inc. | -10.12 Million USD | -345.379% |
| Utah Medical Products, Inc. | 16.77 Million USD | 368.832% |
| DENTSPLY SIRONA Inc. | -85 Million USD | 46.939% |
| Jin Medical International Ltd. | 2.86 Million USD | 1672.999% |